focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,774.50
Ask: 1,775.50
Change: 0.00 (0.00%)
Spread: 1.00 (0.056%)
Open: 1,775.50
High: 1,778.50
Low: 1,769.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

Fri, 15th Dec 2023 16:51

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

The FTSE 100 index gave back 72.62 points, 1.0%, at 7,576.36. It had surged more than 100 points on Thursday.

The FTSE 250 lost 47.99 points, 0.3%, at 19,208.97, though the AIM All-Share ended up 1.47 points, 0.2%, at 739.31.

For the week, the FTSE 100 rose 0.3%, the FTSE 250 added 2.7%, while the AIM All-Share climbed 2.2%.

The Cboe UK 100 ended down 1.0% at 756.32. The Cboe UK 250 lost 0.4% at 16,658.06, though the Cboe Small Companies added 1.2% at 14,297.15.

In European equities on Friday, the CAC 40 in Paris closed up 0.3%, while the DAX 40 in Frankfurt ended flat.

"After the euphoria of the Powell pivot party on Wednesday we got a wake-up call from New York Fed President John Williams when he pushed back on market expectations of a March rate cut saying it was premature to be even considering anything like that. Given the sharp move in bond markets since Wednesday it was perhaps felt necessary to pour a little cold water on the moves of the last 48 hours, with Williams sent out to say it was premature to be thinking in terms of rate cuts. That's not to say they wouldn't happen next year but to be pricing in between 5-6 rate cuts next year as markets appeared to be doing seems to be a case of getting a little carried away," CMC Markets analyst Michael Hewson commented.

The Fed left its benchmark interest rate unchanged, as expected on Wednesday, but signalled rate cuts of as much as 75 basis points in the coming year.

The decision from the Federal Open Market Committee extends a pause in monetary policy that has been in place since July, leaving the federal funds rate at a 22-year high of 5.25% to 5.5%.

But the latest quarterly dot plot showed that most officials expect rates to be in the range of 4.4% to 4.9% by the end of 2024.

A small majority of the Federal Open Market Committee anticipate at least three quarter-point cuts from current levels.

In New York, both the Dow Jones Industrial Average and the S&P 500 were up 0.1%, while the Nasdaq Composite climbed 0.5%.

Analysts at Tower Bridge Advisors commented: "Markets expect it in March although Fed officials don't universally agree. The question for investors is how much of the good news is already priced in. Right now, momentum firmly favours the bulls. That could change quickly once Christmas is over."

The pound was quoted at USD1.2693 at the time of the London equities close on Friday, lower compared to USD1.2762 on Thursday. The euro stood at USD1.0912, lower against USD1.0994. Against the yen, the dollar was trading at JPY141.75, higher compared to JPY141.60.

Shares in pharmaceutical firms struggled on Friday, putting some pressure on London's FTSE 100. AstraZeneca ended 2.7% lower, while GSK lost 2.9%.

Bloomberg on Thursday reported the likes of Astra and GSK have come under scrutiny from US Senator Elizabeth Warren.

The drugmakers have been accused of making sham patents to send prices higher and clip the wings of competition, the news agency reported.

Astra's Symbicort asthma treatment and GSK's Advair and Flovent pair of inhalers are among the products mentioned in a letter sent by Warren to the drugmakers.

Trainline shot up 11% as the threat from the UK government's Great British Railways offering subsided.

Trainline on Thursday noted the UK Department for Transport will no longer pursue creating a ticket retailing website and app, which would have presented competition for the FTSE 250 listing's eponymous platform.

The proposal for a Great British Railways app was first mooted in May 2021 as part of a white paper. GBR is a planned state-owned body that would oversee UK rail transport.

Shares in pub firm Marston's rose 5.3%, adding to Thursday's 6.6% stride. JPMorgan had lifted the stock to 'overweight' from 'neutral' on Thursday.

On AIM, Getech lost 27%.

The Leeds-based geo-energy and green hydrogen company said its client base, 85% of which is based outside of the UK, were showing a "growing level of caution" due to economic and geopolitical instability.

Getech said this has pushed a number of projects initially expected to begin before the end of 2023 into 2024.

As a result, Getech has warned that sales for the full year are not expected to surpass GBP4.4 million, down 14% from GBP5.1 million in 2022.

XLMedia shares slumped 12% after announcing that revenue for 2023 will fall shy.

The London-based global digital media company said that a "change in the revenue profile" of its North American activities had been caused by, among other things, the exit of XLMedia's major partner Barstool from the market.

The group's revenue for the full year is now expected in the range of USD50.0 to USD52.0 million, down from USD71.8 million in 2022. The group also predicted adjusted earnings before interest, tax, depreciation and amortisation of USD12 million to USD14 million, down from USD17.8 million in 2022.

Brent oil was quoted at USD76.34 a barrel late Friday in London, down from USD76.70 late Thursday. Gold was quoted at USD2,034.62 an ounce, down against USD2,039.11.

Monday's economic calendar has the latest Ifo business climate index reading from Germany at 0900 GMT. The week picks up speed with a rate decision from the Bank of Japan on Tuesday, UK inflation data on Wednesday, and a US gross domestic product reading on Thursday.

Monday's local corporate calendar has full-year results from ten-pin bowling firm Hollywood Bowl.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more
4 Jan 2024 14:01

UK dividends calendar - next 7 days

Friday 5 January 
British Land Co PLCdividend payment date
Hill & Smith PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Lok'n Store Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
RS Group PLCdividend payment date
Tate & Lyle PLCdividend payment date
Monday 8 January 
abrdn Equity Income Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
Tuesday 9 January 
no events scheduled 
Wednesday 10 January 
Assura PLCdividend payment date
Bellway PLCdividend payment date
Fidelity Special Values PLCdividend payment date
LXi REIT PLCdividend payment date
Severn Trent PLCdividend payment date
Volex PLCdividend payment date
Vp PLCdividend payment date
Thursday 11 January 
AJ Bell PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
CMC Markets PLCdividend payment date
dotdigital Group PLCex-dividend payment date
Ecora Resources PLCex-dividend payment date
European Assets Trust PLCex-dividend payment date
Foresight Group Holdings Ltdex-dividend payment date
GSK PLCdividend payment date
ICG-Longbow Senior Secured UK Property Debt Investments Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
Keystone Positive Change Investment Trust PLCex-dividend payment date
LondonMetric Property PLCdividend payment date
Murray International Trust PLCex-dividend payment date
National Grid PLCdividend payment date
Primary Health Properties PLCex-dividend payment date
Sage Group PLCex-dividend payment date
Smiths News PLCex-dividend payment date
SSE PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
TR Property Investment Trust PLCdividend payment date
Walker Crips Group PLCex-dividend payment date
WH Smith PLCex-dividend payment date
Worldwide Healthcare Trust PLCdividend payment date
XPS Pensions Group PLCex-dividend payment date
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.